Citation Impact
Citing Papers
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma
2003
Signal transducer and activator of transcription (STAT) signalling and T‐cell lymphomas
2005
Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas
2004
National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis
2014
Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies
2000
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The Immunological Effects of Extracorporeal Photopheresis Unraveled: Induction of Tolerogenic Dendritic Cells In Vitro and Regulatory T Cells In Vivo
2005
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Immunopathogenesis and therapy of cutaneous T cell lymphoma
2005
Extracorporeal photochemotherapy for paediatric patients with graft‐versus‐host disease after haematopoietic stem cell transplantation
2003
U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease
2008
Mycosis Fungoides and Sezary Syndrome
2017
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
2010
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
2010
Mechanistic insights into extracorporeal photochemotherapy: Efficient induction of monocyte-to-dendritic cell maturation
2013
Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome
2015
Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group
2005
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Current management strategies for cutaneous T-cell lymphoma
2004
Graft-versus-host disease
2009 Standout
Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma
2003
Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development In Vivo
2014
Treatment of Cutaneous T Cell Lymphoma
2002
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Quality-of-Life Improvements in Cutaneous T-Cell Lymphoma Patients Treated with Denileukin Diftitox (ONTAK®)
2002
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Extracorporeal photopheresis for the treatment of autoimmune diseases
2015
Extracorporeal Photopheresis in Steroid-Refractory Acute or Chronic Graft-versus-Host Disease: Results of a Systematic Review of Prospective Studies
2014
Primary Cutaneous T-Cell Lymphomas
2006
What's new in the management of cutaneous T-cell lymphoma?
2005
Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy
1992
Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol
2008
Photopheresis: Advances and Use in Systemic Sclerosis
2017
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Treatment of cutaneous T-cell lymphomas
2000
EMERGING NEW THERAPIES FOR CUTANEOUS T-CELL LYMPHOMA
2000
Review of extracorporeal photopheresis in early‐stage (IA, IB, and IIA) cutaneous T‐cell lymphoma
2007
Mycosis fungoides and the Sézary syndrome
2004
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Successful use of miniphotopheresis for the treatment of graft‐versus‐host disease
2014
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
2014
Molecular Docking and Structure-Based Drug Design Strategies
2015 Standout
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Ocular Manifestations of Chronic Graft-Versus-Host Disease in Patients Treated with Extracorporeal Photochemotherapy
2007
Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single‐centre experience
2015
Cutaneous T Cell Lymphoma
2001
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells
2008
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
2007 Standout
CutaneousT ‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
2015
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
2011
How I treat mycosis fungoides and Sézary syndrome
2016
Serological detection of cutaneous T-cell lymphoma-associated antigens
2001
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
2001
Immunogenic Cell Death in Cancer Therapy
2012 Standout
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
2017
Works of Inger Christensen being referenced
Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy
2010
The Immune Response to Class I-Associated Tumor-Specific Cutaneous T-Cell Lymphoma Antigens
1996
Tumor-specific peptides in cutaneous T-cell lymphoma: Association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor
1998
Induction of human tumor-loaded dendritic cells
2001
Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides
2000
Photopheresis in the 1990s
1991
Transimmunization for cutaneous T cell lymphoma: A phase I study
2006
The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells
2002
Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.
1990
The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells
2002